Published in J Protein Chem on August 01, 1997
Architecture and function of metallopeptidase catalytic domains. Protein Sci (2014) 0.92
On the relevance of the Met-turn methionine in metzincins. J Biol Chem (2010) 0.86
Nonnatural amino acid incorporation into the methionine 214 position of the metzincin Pseudomonas aeruginosa alkaline protease. BMC Biochem (2005) 0.79
Enhanced cleavage of type II collagen by collagenases in osteoarthritic articular cartilage. J Clin Invest (1997) 4.31
Structure of the complex formed by bovine trypsin and bovine pancreatic trypsin inhibitor. II. Crystallographic refinement at 1.9 A resolution. J Mol Biol (1974) 3.17
The structure of a complex of recombinant hirudin and human alpha-thrombin. Science (1990) 2.71
The metzincins--topological and sequential relations between the astacins, adamalysins, serralysins, and matrixins (collagenases) define a superfamily of zinc-peptidases. Protein Sci (1995) 2.63
Primary structure of human neutrophil elastase. Proc Natl Acad Sci U S A (1987) 2.45
The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction. EMBO J (1990) 2.44
X-ray crystallographic structure of the light-harvesting biliprotein C-phycocyanin from the thermophilic cyanobacterium Mastigocladus laminosus and its resemblance to globin structures. J Mol Biol (1985) 2.42
The cystatins: protein inhibitors of cysteine proteinases. FEBS Lett (1991) 2.33
The refined crystal structure of bovine beta-trypsin at 1.8 A resolution. II. Crystallographic refinement, calcium binding site, benzamidine binding site and active site at pH 7.0. J Mol Biol (1975) 2.24
Mechanism of inhibition of the human matrix metalloproteinase stromelysin-1 by TIMP-1. Nature (1997) 2.17
Structural basis for the activation of human procaspase-7. Proc Natl Acad Sci U S A (2001) 2.14
Structure of human des(1-45) factor Xa at 2.2 A resolution. J Mol Biol (1993) 2.07
Refined structure of the hirudin-thrombin complex. J Mol Biol (1991) 2.06
Refined three-dimensional structures of two cyanobacterial C-phycocyanins at 2.1 and 2.5 A resolution. A common principle of phycobilin-protein interaction. J Mol Biol (1987) 2.06
Structural basis for the anticoagulant activity of the thrombin-thrombomodulin complex. Nature (2000) 2.04
Structure of astacin and implications for activation of astacins and zinc-ligation of collagenases. Nature (1992) 2.02
Unusual solution properties of proline and its interaction with proteins. Biochim Biophys Acta (1978) 1.94
The ternary microplasmin-staphylokinase-microplasmin complex is a proteinase-cofactor-substrate complex in action. Nat Struct Biol (1998) 1.85
The helping hand of collagenase-3 (MMP-13): 2.7 A crystal structure of its C-terminal haemopexin-like domain. J Mol Biol (1996) 1.82
Matrix metalloproteinase-8 is expressed in rheumatoid synovial fibroblasts and endothelial cells. Regulation by tumor necrosis factor-alpha and doxycycline. J Biol Chem (1997) 1.82
Bovine chymotrypsinogen A X-ray crystal structure analysis and refinement of a new crystal form at 1.8 A resolution. J Mol Biol (1985) 1.81
Crystal structure of gingipain R: an Arg-specific bacterial cysteine proteinase with a caspase-like fold. EMBO J (1999) 1.79
Crystal structure of bovine trypsinogen at 1-8 A resolution. II. Crystallographic refinement, refined crystal structure and comparison with bovine trypsin. J Mol Biol (1977) 1.79
Crystal and molecular structure of a dimer composed of the variable portions of the Bence-Jones protein REI. Eur J Biochem (1974) 1.76
X-ray crystal structure of the complex of human leukocyte elastase (PMN elastase) and the third domain of the turkey ovomucoid inhibitor. EMBO J (1986) 1.76
The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry. Eur J Biochem (1987) 1.75
Crystal structure of the catalytic domain of human tumor necrosis factor-alpha-converting enzyme. Proc Natl Acad Sci U S A (1998) 1.70
Three-dimensional crystal structure of the transcription factor PhoB receiver domain. J Mol Biol (1999) 1.69
The X-ray crystal structure of the catalytic domain of human neutrophil collagenase inhibited by a substrate analogue reveals the essentials for catalysis and specificity. EMBO J (1994) 1.68
The crystal structure of calcium-free human m-calpain suggests an electrostatic switch mechanism for activation by calcium. Proc Natl Acad Sci U S A (2000) 1.65
Crystal structure of the thrombin-hirudin complex: a novel mode of serine protease inhibition. EMBO J (1990) 1.65
A player of many parts: the spotlight falls on thrombin's structure. Thromb Res (1993) 1.64
The 2.5 A X-ray crystal structure of the acid-stable proteinase inhibitor from human mucous secretions analysed in its complex with bovine alpha-chymotrypsin. EMBO J (1988) 1.61
Crystal structures of the membrane-binding C2 domain of human coagulation factor V. Nature (1999) 1.58
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B. Proc Natl Acad Sci U S A (1995) 1.58
The 2.8 A crystal structure of Gla-domainless activated protein C. EMBO J (1996) 1.56
The effect of nisin on murein synthesis. Arch Microbiol (1980) 1.53
The interaction of thrombin with fibrinogen. A structural basis for its specificity. Eur J Biochem (1992) 1.53
The ornithodorin-thrombin crystal structure, a key to the TAP enigma? EMBO J (1996) 1.53
Matrix metalloproteinases and their inhibitors in gingival crevicular fluid and saliva of periodontitis patients. J Clin Periodontol (1996) 1.52
A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase. FEBS Lett (1992) 1.51
Crystal structure analysis and refinement at 2.5 A of hexameric C-phycocyanin from the cyanobacterium Agmenellum quadruplicatum. The molecular model and its implications for light-harvesting. J Mol Biol (1986) 1.50
Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain. Biochem J (1993) 1.49
Inflammation, sepsis, and coagulation. Haematologica (1999) 1.49
Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry (1995) 1.48
Effects of cerebral hypoperfusion on bispectral index: a randomised, controlled animal experiment during haemorrhagic shock. Resuscitation (2010) 1.47
Two heads are better than one: crystal structure of the insect derived double domain Kazal inhibitor rhodniin in complex with thrombin. EMBO J (1995) 1.45
Structural properties of matrix metalloproteinases. Cell Mol Life Sci (1999) 1.43
Human beta-tryptase is a ring-like tetramer with active sites facing a central pore. Nature (1998) 1.43
Insights into the molecular inactivation mechanism of human activated thrombin-activatable fibrinolysis inhibitor. J Thromb Haemost (2010) 1.41
Structure of the thrombin complex with triabin, a lipocalin-like exosite-binding inhibitor derived from a triatomine bug. Proc Natl Acad Sci U S A (1997) 1.38
Mechanism of inhibition of papain by chicken egg white cystatin. Inhibition constants of N-terminally truncated forms and cyanogen bromide fragments of the inhibitor. FEBS Lett (1989) 1.38
First structure of a snake venom metalloproteinase: a prototype for matrix metalloproteinases/collagenases. EMBO J (1993) 1.36
Refined 1.8 A X-ray crystal structure of astacin, a zinc-endopeptidase from the crayfish Astacus astacus L. Structure determination, refinement, molecular structure and comparison with thermolysin. J Mol Biol (1993) 1.34
Induction of the bovine trypsinogen-trypsin transition by peptides sequentially similar to the N-terminus of trypsin. FEBS Lett (1976) 1.34
Refined three-dimensional structure of phycoerythrocyanin from the cyanobacterium Mastigocladus laminosus at 2.7 A. J Mol Biol (1990) 1.33
X-ray structure of active site-inhibited clotting factor Xa. Implications for drug design and substrate recognition. J Biol Chem (1996) 1.33
The expression of angiogenin in tissue samples of different brain tumours and cultured glioma cells. Anticancer Res (2000) 1.32
Fragmentation of human polymorphonuclear-leucocyte collagenase. Biochem J (1993) 1.32
Structural implications for the role of the N terminus in the 'superactivation' of collagenases. A crystallographic study. FEBS Lett (1994) 1.32
The clot thickens: clues provided by thrombin structure. Trends Biochem Sci (1995) 1.30
Lysis inhibition in Escherichia coli infected with bacteriophage T4. J Virol (1967) 1.30
Escherichia coli dihydrodipicolinate synthase. Identification of the active site and crystallization. Biochem J (1992) 1.28
Oxygen radicals as effectors of cartilage destruction. Direct degradative effect on matrix components and indirect action via activation of latent collagenase from polymorphonuclear leukocytes. Arthritis Rheum (1986) 1.28
Matrix metalloproteinases collagenase-2, macrophage elastase, collagenase-3, and membrane type 1-matrix metalloproteinase impair clotting by degradation of fibrinogen and factor XII. J Biol Chem (2000) 1.24
Macrophages release arachidonic acid, prostaglandin E2, and thromboxane in response to late complement components. J Immunol (1984) 1.24
Changing residue 338 in human factor IX from arginine to alanine causes an increase in catalytic activity. J Biol Chem (1998) 1.24
Crystal structure analysis, refinement and enzymatic reaction mechanism of N-carbamoylsarcosine amidohydrolase from Arthrobacter sp. at 2.0 A resolution. J Mol Biol (1992) 1.22
Structural features of a superfamily of zinc-endopeptidases: the metzincins. Curr Opin Struct Biol (1995) 1.22
The 2.0-A crystal structure of tachylectin 5A provides evidence for the common origin of the innate immunity and the blood coagulation systems. Proc Natl Acad Sci U S A (2001) 1.21
Recognition and catabolism of synthetic heterotrimeric collagen peptides by matrix metalloproteinases. Chem Biol (2000) 1.21
Implications of the three-dimensional structure of astacin for the structure and function of the astacin family of zinc-endopeptidases. Eur J Biochem (1993) 1.20
Activation of type IV procollagenases by human tumor-associated trypsin-2. J Biol Chem (1997) 1.19
Insights into MMP-TIMP interactions. Ann N Y Acad Sci (1999) 1.18
Latent and active human polymorphonuclear leukocyte collagenases. Isolation, purification and characterisation. Eur J Biochem (1983) 1.18
Refined 2.3 A X-ray crystal structure of bovine thrombin complexes formed with the benzamidine and arginine-based thrombin inhibitors NAPAP, 4-TAPAP and MQPA. A starting point for improving antithrombotics. J Mol Biol (1992) 1.18
The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition. J Biol Chem (2001) 1.17
Crystal structure of cleaved human alpha 1-antichymotrypsin at 2.7 A resolution and its comparison with other serpins. J Mol Biol (1991) 1.17
The 1.8 A crystal structure of human cathepsin G in complex with Suc-Val-Pro-PheP-(OPh)2: a Janus-faced proteinase with two opposite specificities. EMBO J (1996) 1.17
Structure of astacin with a transition-state analogue inhibitor. Nat Struct Biol (1996) 1.17
X-ray structures of human neutrophil collagenase complexed with peptide hydroxamate and peptide thiol inhibitors. Implications for substrate binding and rational drug design. Eur J Biochem (1995) 1.15
Cloning and expression of human neutrophil lipocalin cDNA derived from bone marrow and ovarian cancer cells. FEBS Lett (1995) 1.14